| Literature DB >> 21871800 |
Hong-Shan Liu1, Shi-Qing Xu, Ming Cheng, Ying Chen, Peng Xia, Keduo Qian, Yi Xia, Zheng-Yu Yang, Chin-Ho Chen, Susan L Morris-Natschke, Kuo-Hsiung Lee.
Abstract
Six 3'R,4'R-di-O-(S)-camphanoyl-2',2'-dimethyldihydropyrano[2,3-f]chromone (DCP) and two 3'R,4'R-di-O-(S)-camphanoyl-(+)-cis-khellactone (DCK) derivatives were designed, synthesized, and evaluated for inhibition of HIV-1(NL4-3) replication in TZM-bl cells. 2-Ethyl-2'-monomethyl-1'-oxa- and -1'-thia-DCP (5a, 6a), as well as 2-ethyl-1'-thia-DCP (7a) exhibited potent anti-HIV activity with EC(50) values of 30, 38 and 54 nM and therapeutic indexes of 152.6, 48.0 and 100.0, respectively, which were better than or comparable to those of the lead compound 2-ethyl-DCP in the same assay. 4-Methyl-1'-thia-DCK (8a) also showed significant inhibitory activity with an EC(50) of 128 nM and TI of 237.9.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21871800 PMCID: PMC3171603 DOI: 10.1016/j.bmcl.2011.07.105
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823